Seamus O'Reilly, Emer Lynch, E Shelley Hwang, Maura Brown, Theresa O'Donovan, Maeve A Hennessy, Geraldine McGinty, Aisling Barry, Catherine S Weadick, Roelof van Leeuwen, Matthijs van de Poll, Giuseppe Curigliano, Martin J O'Sullivan, Alexandra Thomas
{"title":"气候疗法:人类世时代乳腺癌护理的可持续性解决方案。","authors":"Seamus O'Reilly, Emer Lynch, E Shelley Hwang, Maura Brown, Theresa O'Donovan, Maeve A Hennessy, Geraldine McGinty, Aisling Barry, Catherine S Weadick, Roelof van Leeuwen, Matthijs van de Poll, Giuseppe Curigliano, Martin J O'Sullivan, Alexandra Thomas","doi":"10.1016/j.clbc.2024.11.010","DOIUrl":null,"url":null,"abstract":"<p><p>Climate change is the greatest threat to human existence. Currently it impacts breast cancer care by disrupting treatment, by food poverty and economic hardship and through fossil fuel pollution which increases breast cancer incidence. These impacts are greatest in those already experiencing deprivation. However, healthcare (including breast cancer care) is not an innocent bystander in climate change. The carbon emissions of healthcare are equivalent to the continent of Africa with 1.5 billion people. Like all other enterprises healthcare has an obligation to move to net zero carbon emissions. Previously conducted studies of healthcare professionals have highlighted the role of guidance documents to facilitate climate engagement by them. This prompted the formation of an interdisciplinary group to review the intersection points between breast cancer care and planetary health. A solution tree of sustainable solutions for practicing clinicians is proposed which can be integrated into daily clinical practice and into their personal lives.</p>","PeriodicalId":10197,"journal":{"name":"Clinical breast cancer","volume":" ","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Climate Therapy: Sustainability Solutions for Breast Cancer Care in the Anthropocene Era.\",\"authors\":\"Seamus O'Reilly, Emer Lynch, E Shelley Hwang, Maura Brown, Theresa O'Donovan, Maeve A Hennessy, Geraldine McGinty, Aisling Barry, Catherine S Weadick, Roelof van Leeuwen, Matthijs van de Poll, Giuseppe Curigliano, Martin J O'Sullivan, Alexandra Thomas\",\"doi\":\"10.1016/j.clbc.2024.11.010\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Climate change is the greatest threat to human existence. Currently it impacts breast cancer care by disrupting treatment, by food poverty and economic hardship and through fossil fuel pollution which increases breast cancer incidence. These impacts are greatest in those already experiencing deprivation. However, healthcare (including breast cancer care) is not an innocent bystander in climate change. The carbon emissions of healthcare are equivalent to the continent of Africa with 1.5 billion people. Like all other enterprises healthcare has an obligation to move to net zero carbon emissions. Previously conducted studies of healthcare professionals have highlighted the role of guidance documents to facilitate climate engagement by them. This prompted the formation of an interdisciplinary group to review the intersection points between breast cancer care and planetary health. A solution tree of sustainable solutions for practicing clinicians is proposed which can be integrated into daily clinical practice and into their personal lives.</p>\",\"PeriodicalId\":10197,\"journal\":{\"name\":\"Clinical breast cancer\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2024-11-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical breast cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.clbc.2024.11.010\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical breast cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.clbc.2024.11.010","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
Climate Therapy: Sustainability Solutions for Breast Cancer Care in the Anthropocene Era.
Climate change is the greatest threat to human existence. Currently it impacts breast cancer care by disrupting treatment, by food poverty and economic hardship and through fossil fuel pollution which increases breast cancer incidence. These impacts are greatest in those already experiencing deprivation. However, healthcare (including breast cancer care) is not an innocent bystander in climate change. The carbon emissions of healthcare are equivalent to the continent of Africa with 1.5 billion people. Like all other enterprises healthcare has an obligation to move to net zero carbon emissions. Previously conducted studies of healthcare professionals have highlighted the role of guidance documents to facilitate climate engagement by them. This prompted the formation of an interdisciplinary group to review the intersection points between breast cancer care and planetary health. A solution tree of sustainable solutions for practicing clinicians is proposed which can be integrated into daily clinical practice and into their personal lives.
期刊介绍:
Clinical Breast Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of breast cancer. Clinical Breast Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of breast cancer. The main emphasis is on recent scientific developments in all areas related to breast cancer. Specific areas of interest include clinical research reports from various therapeutic modalities, cancer genetics, drug sensitivity and resistance, novel imaging, tumor genomics, biomarkers, and chemoprevention strategies.